Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.
AUTOR(ES)
Okamoto, H
RESUMO
Human immunodeficiency virus (HIV)-encoded trans-activator (Tat) acts through the trans-activation response element RNA stem-loop to increase greatly the processivity of RNA polymerase II. Without Tat, transcription originating from the HIV promoter is attenuated. In this study, we demonstrate that transcriptional activation by Tat in vivo and in vitro requires the C-terminal domain (CTD) of RNA polymerase II. In contrast, the CTD is not required for basal transcription and for the formation of short, attenuated transcripts. Thus, trans-activation by Tat resembles enhancer-dependent activation of transcription. These results suggest that effects of Tat on the processivity of RNA polymerase II require proteins that are associated with the CTD and may result in the phosphorylation of the CTD.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=38099Documentos Relacionados
- Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.
- Evolution of the RNA polymerase II C-terminal domain
- Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure.
- Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C.
- Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C
